Bayer AG and J&J’s subsidiary Janssen Pharmaceuticals Inc. have now formalized a $775 settlement of more than 25,000 lawsuits over their blood-thinning drug Xarelto. The cases are pending in both federal and state courts and this may be seen as a run up to Bayer’s next settlement, in their now seen as a bad-for-earnings purchase of Monsanto and its Federal Roundup MDL 2471 docket, as well as cases filed in state courts.
FDA uncovered which puts US consumers at major risk
We want to wish all of our subscribers, claimants both past and future a happy and healthy 2019
MSNBC is the premier destination for in-depth analysis of daily headlines, insightful political commentary and informed perspectives.
The Dangers of Invokana: A diabetes drug - deadly side effects?